Shukra Pharmaceuticals Limited (BOM:524632)

Shukra Pharmaceuticals Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	95.75	185.37	44.07	7.51	1.88
Depreciation & Amortization	30.05	20.5	18.38	16.62	14.74
Other Operating Activities	-8.85	2.21	-4.5	0.8	-1.24
Change in Accounts Receivable	157.46	56.74	-227.86	23.47	-9.52
Change in Inventory	-76.39	8.42	7.97	-22.72	-2.95
Change in Accounts Payable	19.95	-261.51	260.97	32.61	-9.52
Change in Other Net Operating Assets	-138.79	-63.7	-67.33	21.6	11.98
Operating Cash Flow	79.18	-51.97	31.7	79.89	5.37
Operating Cash Flow Growth	-	-	-60.32%	1386.79%	-54.90%
Capital Expenditures	-27.43	-17.6	-44.91	-15.5	-17.91
Sale of Property, Plant & Equipment	-	-	-	-	0.05
Investment in Securities	-	-	-	-0.09	-1.43
Other Investing Activities	14.79	5.59	0.64	0.31	0.34
Investing Cash Flow	-12.64	-12.01	-44.27	-15.28	-18.95
Long-Term Debt Issued	4.56	-	6.42	-	17.36
Long-Term Debt Repaid	-	-11.12	-	-63.94	-
Net Debt Issued (Repaid)	4.56	-11.12	6.42	-63.94	17.36
Issuance of Common Stock	-	138.72	46.28	-	-
Common Dividends Paid	-43.79	-0.7	-0.73	-	-
Other Financing Activities	-5.95	-2.85	-2.56	-2.81	-
Financing Cash Flow	-45.18	124.05	49.41	-66.75	17.36
Miscellaneous Cash Flow Adjustments	-	0	-	-	-
Net Cash Flow	21.37	60.08	36.84	-2.15	3.78
Free Cash Flow	51.75	-69.57	-13.22	64.39	-12.54
Free Cash Flow Margin	14.07%	-9.10%	-2.22%	31.43%	-11.20%
Free Cash Flow Per Share	0.12	-0.16	-0.20	1.03	-0.20
Cash Interest Paid	5.95	2.85	2.56	2.81	0.13
Cash Income Tax Paid	37.62	6.25	2.5	4.37	-
Levered Free Cash Flow	41.04	-123.17	-43.52	57.98	-13.32
Unlevered Free Cash Flow	44.76	-121.45	-41.92	59.74	-13.24
Change in Net Working Capital	44.94	246.91	44.51	-50.66	11.81

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.